Neuraminidase inhibitor resistance in in
✍
Phillip Andrew Reece
📂
Article
📅
2007
🏛
John Wiley and Sons
🌐
English
⚖ 145 KB
## Abstract Zanamivir and oseltamivir, the currentlymarketed influenza virus neuraminidase inhibitors (NAIs), are prescribed for the treatment and prophylaxis of influenza and are being stockpiled for pandemic influenza. Oseltamivir resistance has been reported in up to 2% of patients in clinical t